Healthcare Global Enterprises Limited — Financials & Forensics
Sector: Healthcare · NSE: HCG · BSE: 539787 · ISIN: INE075I01017
18 Aug 2026
Add HCG to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | ₹1,398 Cr | ₹1,694 Cr | ₹1,912 Cr | ₹2,223 Cr | ₹2,545 Cr |
| EBITDA | ₹238 Cr | ₹299 Cr | ₹330 Cr | ₹387 Cr | ₹466 Cr |
| EBITDA margin | 17.0% | 17.6% | 17.2% | 17.4% | 18.3% |
| Profit after tax | ₹54 Cr | ₹29 Cr | ₹48 Cr | ₹44 Cr | ₹14 Cr |
Deeper analysis
Recent filings by Healthcare Global Enterprises Limited
-
Press release on Unaudited Financial Results (Standalone and Consolidated) of the Company for the qu
06 Aug 2026 · Financial Results
-
Investor Presentation on Unaudited Financial Results (Standalone and Consolidated) of the Company fo
06 Aug 2026 · Financial Results
-
Monitoring Agency Report for the quarter ended June 30, 2026, in relation to the Rights Issue of the
06 Aug 2026 · Regulatory Compliance
-
Statement of Variation or Deviation for funds raised through Rights Issue for the quarter ended June
06 Aug 2026 · Regulatory Compliance
-
Appointment
06 Aug 2026 · Regulatory Compliance
Never miss a filing again
About Healthcare Global Enterprises Limited on Indian Stock Alerts
Indian Stock Alerts tracks Healthcare Global Enterprises Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.